<DOC>
	<DOCNO>NCT00236548</DOCNO>
	<brief_summary>The purpose study assess usefulness RisperdalÂ® ConstaÂ® Treatment Guidebook help doctor switch adult patient take risperidone tablet daily mouth take long-acting risperidone injection . The study also evaluate effectiveness safety long-acting risperidone effect patient satisfaction .</brief_summary>
	<brief_title>Evaluation Usefulness Doctors Risperdal Consta Treatment Guidebook Over Three-month Period During Which Adult Patients With Schizophrenia Schizoaffective Disorder Are Switching From Daily Doses Risperidone Tablets Long-acting Risperidone Injection</brief_title>
	<detailed_description>Many patient take oral medication treat schizophrenia schizoaffective disorder trouble take medication every day . They may want take , may forget . Risperidone injection , give every 2 week , expect effective risperidone tablet take day . The option get injection every 2 week rather take tablet every day may help patient keep medication administration schedule could help reduce symptom disease . The study ass usefulness Risperdal® Consta® Treatment Guidebook Community Mental Health Center setting , period three month . This Guidebook design help doctor switch adult patient oral risperidone tablet long-acting risperidone give every 2 week injection . During study , patient continue take oral risperidone 2 week follow initiation risperidone injection , give every 2 week 12-week period . Physical examination laboratory test perform test safety risperidone injection . Both patient doctor ask question usefulness guidebook effectiveness injection . The objective study demonstrate effectiveness Risperdal® Consta™ Treatment Guidebook switch patient schizophrenia schizoaffective disorder daily oral risperidone long-acting risperidone injection . In addition , safety evaluation assess throughout study . Risperidone oral tablet , 2 6 milligram per day first 2 week initiation long-acting risperidone injection ; long-acting risperidone injection give dos 25 , 37.5 , 50 milligram per 2 milliliter injection every 2 week 12 week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder stable respect disease symptoms medical condition take oral risperidone dose 2 6 milligram per day 4 week start study female , use birth control . Hospitalized within past 4 week treat exacerbation symptom schizophrenia risk injury self others electroconvulsive therapy within past year presence liver kidney impairment use oral antipsychotic ( risperidone ) within past 4 week , injected antipsychotic within past 3 month , clozapine within past 60 day , longacting risperidone earlier study pregnant breastfeeding use birth control abuse drug alcohol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>patient compliance</keyword>
	<keyword>long-acting risperidone</keyword>
	<keyword>intramuscular injection</keyword>
	<keyword>Treatment Guidebook</keyword>
</DOC>